Delivery Order SPE2DB25D2207-SPE2DB25FQRWP
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,958.75 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was awarded without set-aside designations through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 18, 2025, with completion targeted for August 19, 2025. This delivery order represents a firm fixed-price contract with no set-aside designation, issued under a competitive procurement process. The award is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as...
- The Defense Logistics Agency awarded a delivery order valued at $1,801.80 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 7, 2025. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of August 8, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,210.60 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pens on September 11, 2025, with completion expected by September 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,342.25 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pens on July 21, 2025, with completion targeted for July 22, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running...
- The Defense Logistics Agency awarded a delivery order valued at $1,514.37 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 12, 2025, with an ultimate completion date of August 13, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens valued at $4,504.50. This is a firm fixed price delivery order with an ultimate completion date of September 26, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens valued at $4,911.97 on August 25, 2025. This competitively awarded, firm fixed-price contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor vehicle extending through December 2026. The delivery order is set to be completed...
- The Defense Logistics Agency awarded a $7,436.37 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on August 4, 2025, with completion scheduled for August 5, 2025. This contract employs firm fixed pricing and was competitively awarded without set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a leading pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,956.49 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 25, 2025, with completion scheduled for August 26, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The pharmaceutical distributor...
- SPE2DB25D2207Indefinite Delivery Contract
- SPE2DB25D2207-SPE2DB25FQRWPDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,085.37 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 mL pens on September 26, 2025, with completion targeted for September 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal pharmaceutical procurement needs. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and primary distribution center for federal medical supply operations. This delivery order is executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026. The IDC serves as the primary mechanism through which AmerisourceBergen supplies pharmaceutical products and medical supplies to support military healthcare systems globally, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The company's established position as a major pharmaceutical distributor enables it to fulfill diverse medical procurement requirements ranging from specialty medications to vaccines and medical devices across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/26/25 |